References
- AGSSERER, W. A., and BIROS, M. L., 1995, High-resolution analysis and purification of synthetic oligonucleotides with strong anion-exchange HPLC. Bio Technique 19, 136–139.
- BERTLING, W. M., GAREIS, M., PASP6LEEVA, V., Z(MMER, A., KREUTER, J., NURNBERG, E., and HARRER, P., 1991, Use of liposames, viral capsids, and nanoparticles as DNA carriers. Journal of Biotechnology and Applied Biochemistry, 13, 390–405.
- CHAVANY, C., LE Do, T. COUVREUR, P., PUISIEUX, F., and HELENE, C., 1992, Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonu-cleotides. Pharmaceutical Research, 9, 441–449.
- CHERNG, J. Y., VAN DE WETERING, P., TALSMA, H., CROMMELIN, D. J., and HENNTNK, W. E., 1996, Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharmaceutical Re-search, 13, 1038–1042.
- HOFLAND, H., and HUANG, L., 1995, Inhibition of human ovarian carcinoma cell proliferation by liposame-plasmid DNA complex. Biochemical & Biophysical Research Communicatons, 207, 492–496.
- KoNDo, T., ARAI, S., KUWABARA, M., VOSHEI., G., and KANo, E., 1985, Damage in DNA irradiated with 1.2 MHz ultrasound and its effect on template activity of DNA for RNA synthesis. Radiation Research, 104, 284–292.
- KREUTER, J., 1983, Evaluation of nanoparticles as drug-delivery systems. II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 micron), liposomes, and emulsions. Pharmaceutica Acta Helvetiae, 58, 217–226.
- KULKA, M., SMITH, C. C., AURELIAN, L., FISHELEVICH, R., MEADE, K., MILLER, P., and Ts'o, P. 0. P., 1989, Site specificity of the inhibitory effects of oligo(nucleosidemethyl-phosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proceedings of the National Academy of Sciences (USA), 86, 6868–6872.
- MACDONALD, R. C., MACDONALD, R. I., MENCO, B. P. M., TAKESHITA, K., SUBBARAO, N. K., and Hu, L.-R., 1991, Small-volume extrusion apparatus for preparation of large unilamellar vesicles. Biochemica et Biophysica Acta, 1061, 297–303.
- MILLER, D. L., THOMAS, R. M., and FRAZIER, M. E., 1991a, Single strand breaks in CHO cell DNA induced by ultrasonic cavitation in vitro. Ultrasound in Medicine & Biology, 17, 401–406.
- MILLER, D. L., THOMAS, R. M., and FRAZIER, M. E., 1991b, Ultrasonic cavitation indirectly induces single strand breaks in DNA of viable cells in vitro by the action of residual hydrogen peroxide. Ultrasound in Medicine & Biology, 17, 729–735.
- SMITH, C. C., AURELIAN, L., REDDY, M. P., MILLER, P. S., and Ts'o, P. 0. P., 1986, Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proceedings of the National Academy of Sciences (USA), 83, 2787–2791.
- SoLoDIN, I., BROWN, C. S., BRUNO, M. S., CHOW, C. Y., JANG, E. H., Ds, R. J., and HEATH, T. D., 1995, A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry, 34, 13537-13 544.
- WAsAN, E. K., REIMER, D. L., and BALLY, M. B., 1996, Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. Journal of Pharmaceutical Sciences, 85, 427–433.
- WYBER, J. A., ANDREWS, J., and D'EMANUELE, A., 1997, The use of sonication for the efficient delivery of plasmid DNA into cells Pharmaceutical Research, 14, 750–756.
- ZIMMER, A., ATMACA-ABDEL AZIZ, S., GILBERT, M., WERNER, D., and NOE, C. R., 1998, Synthesis of cationic lipids for delivery of antisense oligonucleotides. Europ. I Pharm. Biopharm., in press.
- ZOBEL, H.-P., KREUTER, J., WERNER, D., NOE, C. R., KümEL, G., and ZIMMER, A., 1997, Cationic polyhexylcyanoarrylate nanoparticles as carriers for antisense oligonucleo-tides. Antisense & Nucleic Acid Drug Development, 7, 483–493.
- ZOBEL, H.-P., ZIMMER, A., ATMASA-ABDEL AZIZ, S., GILBERT, M., WERNER, D., NOE, C. R., KREUTER, J., and STIENEKER, F., 1998a, Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: synthesis of the monomers, dependence of the physical properties on the polymerization methods. Europ. I Pharm. Biopharm., in press.
- ZOBEL, H.-P., STIENEKER, F., ATMACA-ABDEL AZIZ, S., GILBERT, M., WERNER, D., NOE, C. R., KREUTER, J., and ZimmER, A., 1998b, Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: toxicity of copolymer nanoparticles and loading characteristics of antisense oligonucleotides. Europ. I Pharm. Biopharm., in press.